世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および日本のNimesulide市場の洞察、2027年までの予測

世界および日本のNimesulide市場の洞察、2027年までの予測


Global and Japan Nimesulide Market Insights, Forecast to 2027

Nimesulideは、比較的COX-2選択性の高い非ステロイド性抗炎症薬(NSAID)で、鎮痛・解熱作用があります。承認された効能・効果は、12歳以上の青年期および成人期における急性痛、変形性関節症、原発性月経困難症... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ
2021年11月26日 US$3,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

Nimesulideは、比較的COX-2選択性の高い非ステロイド性抗炎症薬(NSAID)で、鎮痛・解熱作用があります。承認された効能・効果は、12歳以上の青年期および成人期における急性痛、変形性関節症、原発性月経困難症の対症療法です。肝毒性の懸念があるため、多くの国で販売中止となっています。

市場分析と洞察世界および日本のNimesulide市場
本レポートでは、世界および日本のNimesulide市場に焦点を当てています。
2020年のNimesulideの世界市場規模はXX百万米ドルで、2021-2027年の間にXX%のCAGRで、2027年末にはXX百万米ドルに達すると予想されています。日本では、Nimesulideの市場規模は2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX%のCAGRで成長すると予測されています。

世界のNimesulideの範囲と市場規模
Nimesulide市場は、地域(国)別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のNimesulide市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、地域(国)別、タイプ別、アプリケーション別に、2016年から2027年までの収益と予測に焦点を当てています。
日本市場では、2016年から2027年の期間で、プレイヤー別、タイプ別、アプリケーション別のNimesulide市場規模に焦点を当てています。主要プレイヤーには、日本で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。

タイプ別セグメント
錠剤
カプセル
顆粒
その他

用途別セグメント
慢性関節炎
原発性月経困難症
外傷性疼痛
手術後の痛み
その他

地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
UAE

会社別
ヘルシン
Therabel
ベーリンガーインゲルハイム(Boehringer Ingelheim
メルク
ロシュ
ノバルティス
メデア・リサーチ
チノイン
GSK
アルター
バイエル
ラファ・ラボラトリーズ
グルーネンタール
ファイザー
サノフィ
イタルファルマコ
Lepu Pharmaceutical
南昌飛鴻製薬
シノファーム
広東龍神製薬
康子製薬
湖北修邦製薬
牡丹江霊台製薬
貴州Jisheng Pharmaceutical
天津和志医薬集団
広東易修製薬
広州白雲山製薬
海南華潤華製薬
南京正科製薬


ページTOPに戻る


目次

1 Study Coverage
1.1 Nimesulide Product Introduction
1.2 Market by Type
1.2.1 Global Nimesulide Market Size Growth Rate by Type
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Granules
1.2.5 Other
1.3 Market by Application
1.3.1 Global Nimesulide Market Size Growth Rate by Application
1.3.2 Chronic Arthritis
1.3.3 Primary Dysmenorrhea
1.3.4 Traumatic Pain
1.3.5 Post-Operative Pain
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Nimesulide Market Size, Estimates and Forecasts
2.1.1 Global Nimesulide Revenue 2016-2027
2.1.2 Global Nimesulide Sales 2016-2027
2.2 Global Nimesulide, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Nimesulide Historical Market Size by Region (2016-2021)
2.3.1 Global Nimesulide Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Nimesulide Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Nimesulide Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Nimesulide Sales Forecast by Region (2022-2027)
2.4.2 Global Nimesulide Revenue Forecast by Region (2022-2027)

3 Global Nimesulide Competitor Landscape by Players
3.1 Global Top Nimesulide Manufacturers by Sales
3.1.1 Global Nimesulide Sales by Manufacturer (2016-2021)
3.1.2 Global Nimesulide Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Nimesulide Manufacturers by Revenue
3.2.1 Key Nimesulide Manufacturers Covered: Ranking by Revenue
3.2.2 Global Nimesulide Revenue by Manufacturers (2016-2021)
3.2.3 Global Nimesulide Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Nimesulide Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Nimesulide Revenue in 2020
3.2.6 Global Nimesulide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Nimesulide Price by Manufacturers
3.4 Global Nimesulide Manufacturing Base Distribution, Product Types
3.4.1 Nimesulide Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nimesulide Product Type
3.4.3 Date of International Manufacturers Enter into Nimesulide Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Nimesulide Market Size by Type (2016-2021)
4.1.1 Global Nimesulide Sales by Type (2016-2021)
4.1.2 Global Nimesulide Revenue by Type (2016-2021)
4.1.3 Nimesulide Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Nimesulide Market Size Forecast by Type (2022-2027)
4.2.1 Global Nimesulide Sales Forecast by Type (2022-2027)
4.2.2 Global Nimesulide Revenue Forecast by Type (2022-2027)
4.2.3 Nimesulide Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Nimesulide Market Size by Application (2016-2021)
5.1.1 Global Nimesulide Sales by Application (2016-2021)
5.1.2 Global Nimesulide Revenue by Application (2016-2021)
5.1.3 Nimesulide Price by Application (2016-2021)
5.2 Nimesulide Market Size Forecast by Application (2022-2027)
5.2.1 Global Nimesulide Sales Forecast by Application (2022-2027)
5.2.2 Global Nimesulide Revenue Forecast by Application (2022-2027)
5.2.3 Global Nimesulide Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan Nimesulide Market Size YoY Growth 2016-2027
6.1.1 Japan Nimesulide Sales YoY Growth 2016-2027
6.1.2 Japan Nimesulide Revenue YoY Growth 2016-2027
6.1.3 Japan Nimesulide Market Share in Global Market 2016-2027
6.2 Japan Nimesulide Market Size by Players (International and Local Players)
6.2.1 Japan Top Nimesulide Players by Sales (2016-2021)
6.2.2 Japan Top Nimesulide Players by Revenue (2016-2021)
6.3 Japan Nimesulide Historic Market Review by Type (2016-2021)
6.3.1 Japan Nimesulide Sales Market Share by Type (2016-2021)
6.3.2 Japan Nimesulide Revenue Market Share by Type (2016-2021)
6.3.3 Japan Nimesulide Price by Type (2016-2021)
6.4 Japan Nimesulide Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Nimesulide Sales Forecast by Type (2022-2027)
6.4.2 Japan Nimesulide Revenue Forecast by Type (2022-2027)
6.4.3 Japan Nimesulide Price Forecast by Type (2022-2027)
6.5 Japan Nimesulide Historic Market Review by Application (2016-2021)
6.5.1 Japan Nimesulide Sales Market Share by Application (2016-2021)
6.5.2 Japan Nimesulide Revenue Market Share by Application (2016-2021)
6.5.3 Japan Nimesulide Price by Application (2016-2021)
6.6 Japan Nimesulide Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Nimesulide Sales Forecast by Application (2022-2027)
6.6.2 Japan Nimesulide Revenue Forecast by Application (2022-2027)
6.6.3 Japan Nimesulide Price Forecast by Application (2022-2027)

7 North America
7.1 North America Nimesulide Market Size YoY Growth 2016-2027
7.2 North America Nimesulide Market Facts & Figures by Country
7.2.1 North America Nimesulide Sales by Country (2016-2021)
7.2.2 North America Nimesulide Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Nimesulide Market Size YoY Growth 2016-2027
8.2 Asia Pacific Nimesulide Market Facts & Figures by Region
8.2.1 Asia Pacific Nimesulide Sales by Region (2016-2021)
8.2.2 Asia Pacific Nimesulide Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Nimesulide Market Size YoY Growth 2016-2027
9.2 Europe Nimesulide Market Facts & Figures by Country
9.2.1 Europe Nimesulide Sales by Country (2016-2021)
9.2.2 Europe Nimesulide Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Nimesulide Market Size YoY Growth 2016-2027
10.2 Latin America Nimesulide Market Facts & Figures by Country
10.2.1 Latin America Nimesulide Sales by Country (2016-2021)
10.2.2 Latin America Nimesulide Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Nimesulide Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Nimesulide Market Facts & Figures by Country
11.2.1 Middle East and Africa Nimesulide Sales by Country (2016-2021)
11.2.2 Middle East and Africa Nimesulide Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Helsinn
12.1.1 Helsinn Corporation Information
12.1.2 Helsinn Description and Business Overview
12.1.3 Helsinn Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Helsinn Nimesulide Products Offered
12.1.5 Helsinn Recent Development
12.2 Therabel
12.2.1 Therabel Corporation Information
12.2.2 Therabel Description and Business Overview
12.2.3 Therabel Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Therabel Nimesulide Products Offered
12.2.5 Therabel Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Corporation Information
12.3.2 Boehringer Ingelheim Description and Business Overview
12.3.3 Boehringer Ingelheim Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Boehringer Ingelheim Nimesulide Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Merck
12.4.1 Merck Corporation Information
12.4.2 Merck Description and Business Overview
12.4.3 Merck Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merck Nimesulide Products Offered
12.4.5 Merck Recent Development
12.5 Roche
12.5.1 Roche Corporation Information
12.5.2 Roche Description and Business Overview
12.5.3 Roche Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Roche Nimesulide Products Offered
12.5.5 Roche Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Description and Business Overview
12.6.3 Novartis Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novartis Nimesulide Products Offered
12.6.5 Novartis Recent Development
12.7 Medea Research
12.7.1 Medea Research Corporation Information
12.7.2 Medea Research Description and Business Overview
12.7.3 Medea Research Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Medea Research Nimesulide Products Offered
12.7.5 Medea Research Recent Development
12.8 Chinoin
12.8.1 Chinoin Corporation Information
12.8.2 Chinoin Description and Business Overview
12.8.3 Chinoin Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Chinoin Nimesulide Products Offered
12.8.5 Chinoin Recent Development
12.9 GSK
12.9.1 GSK Corporation Information
12.9.2 GSK Description and Business Overview
12.9.3 GSK Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.9.4 GSK Nimesulide Products Offered
12.9.5 GSK Recent Development
12.10 Alter
12.10.1 Alter Corporation Information
12.10.2 Alter Description and Business Overview
12.10.3 Alter Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Alter Nimesulide Products Offered
12.10.5 Alter Recent Development
12.11 Helsinn
12.11.1 Helsinn Corporation Information
12.11.2 Helsinn Description and Business Overview
12.11.3 Helsinn Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Helsinn Nimesulide Products Offered
12.11.5 Helsinn Recent Development
12.12 Rafa Laboratories
12.12.1 Rafa Laboratories Corporation Information
12.12.2 Rafa Laboratories Description and Business Overview
12.12.3 Rafa Laboratories Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Rafa Laboratories Products Offered
12.12.5 Rafa Laboratories Recent Development
12.13 Grunenthal
12.13.1 Grunenthal Corporation Information
12.13.2 Grunenthal Description and Business Overview
12.13.3 Grunenthal Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Grunenthal Products Offered
12.13.5 Grunenthal Recent Development
12.14 Pfizer
12.14.1 Pfizer Corporation Information
12.14.2 Pfizer Description and Business Overview
12.14.3 Pfizer Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Pfizer Products Offered
12.14.5 Pfizer Recent Development
12.15 Sanofi
12.15.1 Sanofi Corporation Information
12.15.2 Sanofi Description and Business Overview
12.15.3 Sanofi Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Sanofi Products Offered
12.15.5 Sanofi Recent Development
12.16 Italfarmaco
12.16.1 Italfarmaco Corporation Information
12.16.2 Italfarmaco Description and Business Overview
12.16.3 Italfarmaco Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Italfarmaco Products Offered
12.16.5 Italfarmaco Recent Development
12.17 Lepu Pharmaceutical
12.17.1 Lepu Pharmaceutical Corporation Information
12.17.2 Lepu Pharmaceutical Description and Business Overview
12.17.3 Lepu Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Lepu Pharmaceutical Products Offered
12.17.5 Lepu Pharmaceutical Recent Development
12.18 Nanchang Feihong Pharmaceutical
12.18.1 Nanchang Feihong Pharmaceutical Corporation Information
12.18.2 Nanchang Feihong Pharmaceutical Description and Business Overview
12.18.3 Nanchang Feihong Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Nanchang Feihong Pharmaceutical Products Offered
12.18.5 Nanchang Feihong Pharmaceutical Recent Development
12.19 Sinopharm
12.19.1 Sinopharm Corporation Information
12.19.2 Sinopharm Description and Business Overview
12.19.3 Sinopharm Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Sinopharm Products Offered
12.19.5 Sinopharm Recent Development
12.20 Guangdong Longxin Pharmaceutical
12.20.1 Guangdong Longxin Pharmaceutical Corporation Information
12.20.2 Guangdong Longxin Pharmaceutical Description and Business Overview
12.20.3 Guangdong Longxin Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Guangdong Longxin Pharmaceutical Products Offered
12.20.5 Guangdong Longxin Pharmaceutical Recent Development
12.21 Kangzhi Pharmaceutical
12.21.1 Kangzhi Pharmaceutical Corporation Information
12.21.2 Kangzhi Pharmaceutical Description and Business Overview
12.21.3 Kangzhi Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Kangzhi Pharmaceutical Products Offered
12.21.5 Kangzhi Pharmaceutical Recent Development
12.22 Hubei Shubang Pharmaceutical
12.22.1 Hubei Shubang Pharmaceutical Corporation Information
12.22.2 Hubei Shubang Pharmaceutical Description and Business Overview
12.22.3 Hubei Shubang Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Hubei Shubang Pharmaceutical Products Offered
12.22.5 Hubei Shubang Pharmaceutical Recent Development
12.23 Mudanjiang Lingtai Pharmaceutical
12.23.1 Mudanjiang Lingtai Pharmaceutical Corporation Information
12.23.2 Mudanjiang Lingtai Pharmaceutical Description and Business Overview
12.23.3 Mudanjiang Lingtai Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Mudanjiang Lingtai Pharmaceutical Products Offered
12.23.5 Mudanjiang Lingtai Pharmaceutical Recent Development
12.24 Guizhou Jisheng Pharmaceutical
12.24.1 Guizhou Jisheng Pharmaceutical Corporation Information
12.24.2 Guizhou Jisheng Pharmaceutical Description and Business Overview
12.24.3 Guizhou Jisheng Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Guizhou Jisheng Pharmaceutical Products Offered
12.24.5 Guizhou Jisheng Pharmaceutical Recent Development
12.25 Tianjin Hezhi Pharmaceutical Group
12.25.1 Tianjin Hezhi Pharmaceutical Group Corporation Information
12.25.2 Tianjin Hezhi Pharmaceutical Group Description and Business Overview
12.25.3 Tianjin Hezhi Pharmaceutical Group Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.25.4 Tianjin Hezhi Pharmaceutical Group Products Offered
12.25.5 Tianjin Hezhi Pharmaceutical Group Recent Development
12.26 Guangdong Yishu Pharmaceutical
12.26.1 Guangdong Yishu Pharmaceutical Corporation Information
12.26.2 Guangdong Yishu Pharmaceutical Description and Business Overview
12.26.3 Guangdong Yishu Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.26.4 Guangdong Yishu Pharmaceutical Products Offered
12.26.5 Guangdong Yishu Pharmaceutical Recent Development
12.27 Guangzhou Baiyunshan Pharmaceutical
12.27.1 Guangzhou Baiyunshan Pharmaceutical Corporation Information
12.27.2 Guangzhou Baiyunshan Pharmaceutical Description and Business Overview
12.27.3 Guangzhou Baiyunshan Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.27.4 Guangzhou Baiyunshan Pharmaceutical Products Offered
12.27.5 Guangzhou Baiyunshan Pharmaceutical Recent Development
12.28 Hainan Huluwa Pharmaceutical
12.28.1 Hainan Huluwa Pharmaceutical Corporation Information
12.28.2 Hainan Huluwa Pharmaceutical Description and Business Overview
12.28.3 Hainan Huluwa Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.28.4 Hainan Huluwa Pharmaceutical Products Offered
12.28.5 Hainan Huluwa Pharmaceutical Recent Development
12.29 Nanjing Zhengke Pharmaceutical
12.29.1 Nanjing Zhengke Pharmaceutical Corporation Information
12.29.2 Nanjing Zhengke Pharmaceutical Description and Business Overview
12.29.3 Nanjing Zhengke Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.29.4 Nanjing Zhengke Pharmaceutical Products Offered
12.29.5 Nanjing Zhengke Pharmaceutical Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Nimesulide Industry Trends
13.2 Nimesulide Market Drivers
13.3 Nimesulide Market Challenges
13.4 Nimesulide Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nimesulide Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る


 

Summary

Nimesulide is a relatively COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. Its approved indications are the treatment of acute pain, the symptomatic treatment of osteoarthritis and primary dysmenorrhoea in adolescents and adults above 12 years old. Due to concerns about the risk of hepatotoxicity, nimesulide has been withdrawn from market in many countries.

Market Analysis and Insights: Global and Japan Nimesulide Market
This report focuses on global and Japan Nimesulide market.
In 2020, the global Nimesulide market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan the Nimesulide market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Nimesulide Scope and Market Size
Nimesulide market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Nimesulide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Nimesulide market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Tablets
Capsule
Granules
Other

Segment by Application
Chronic Arthritis
Primary Dysmenorrhea
Traumatic Pain
Post-Operative Pain
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Helsinn
Therabel
Boehringer Ingelheim
Merck
Roche
Novartis
Medea Research
Chinoin
GSK
Alter
Bayer
Rafa Laboratories
Grunenthal
Pfizer
Sanofi
Italfarmaco
Lepu Pharmaceutical
Nanchang Feihong Pharmaceutical
Sinopharm
Guangdong Longxin Pharmaceutical
Kangzhi Pharmaceutical
Hubei Shubang Pharmaceutical
Mudanjiang Lingtai Pharmaceutical
Guizhou Jisheng Pharmaceutical
Tianjin Hezhi Pharmaceutical Group
Guangdong Yishu Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Hainan Huluwa Pharmaceutical
Nanjing Zhengke Pharmaceutical



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Nimesulide Product Introduction
1.2 Market by Type
1.2.1 Global Nimesulide Market Size Growth Rate by Type
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Granules
1.2.5 Other
1.3 Market by Application
1.3.1 Global Nimesulide Market Size Growth Rate by Application
1.3.2 Chronic Arthritis
1.3.3 Primary Dysmenorrhea
1.3.4 Traumatic Pain
1.3.5 Post-Operative Pain
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Nimesulide Market Size, Estimates and Forecasts
2.1.1 Global Nimesulide Revenue 2016-2027
2.1.2 Global Nimesulide Sales 2016-2027
2.2 Global Nimesulide, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Nimesulide Historical Market Size by Region (2016-2021)
2.3.1 Global Nimesulide Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Nimesulide Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Nimesulide Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Nimesulide Sales Forecast by Region (2022-2027)
2.4.2 Global Nimesulide Revenue Forecast by Region (2022-2027)

3 Global Nimesulide Competitor Landscape by Players
3.1 Global Top Nimesulide Manufacturers by Sales
3.1.1 Global Nimesulide Sales by Manufacturer (2016-2021)
3.1.2 Global Nimesulide Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Nimesulide Manufacturers by Revenue
3.2.1 Key Nimesulide Manufacturers Covered: Ranking by Revenue
3.2.2 Global Nimesulide Revenue by Manufacturers (2016-2021)
3.2.3 Global Nimesulide Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Nimesulide Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Nimesulide Revenue in 2020
3.2.6 Global Nimesulide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Nimesulide Price by Manufacturers
3.4 Global Nimesulide Manufacturing Base Distribution, Product Types
3.4.1 Nimesulide Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nimesulide Product Type
3.4.3 Date of International Manufacturers Enter into Nimesulide Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Nimesulide Market Size by Type (2016-2021)
4.1.1 Global Nimesulide Sales by Type (2016-2021)
4.1.2 Global Nimesulide Revenue by Type (2016-2021)
4.1.3 Nimesulide Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Nimesulide Market Size Forecast by Type (2022-2027)
4.2.1 Global Nimesulide Sales Forecast by Type (2022-2027)
4.2.2 Global Nimesulide Revenue Forecast by Type (2022-2027)
4.2.3 Nimesulide Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Nimesulide Market Size by Application (2016-2021)
5.1.1 Global Nimesulide Sales by Application (2016-2021)
5.1.2 Global Nimesulide Revenue by Application (2016-2021)
5.1.3 Nimesulide Price by Application (2016-2021)
5.2 Nimesulide Market Size Forecast by Application (2022-2027)
5.2.1 Global Nimesulide Sales Forecast by Application (2022-2027)
5.2.2 Global Nimesulide Revenue Forecast by Application (2022-2027)
5.2.3 Global Nimesulide Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan Nimesulide Market Size YoY Growth 2016-2027
6.1.1 Japan Nimesulide Sales YoY Growth 2016-2027
6.1.2 Japan Nimesulide Revenue YoY Growth 2016-2027
6.1.3 Japan Nimesulide Market Share in Global Market 2016-2027
6.2 Japan Nimesulide Market Size by Players (International and Local Players)
6.2.1 Japan Top Nimesulide Players by Sales (2016-2021)
6.2.2 Japan Top Nimesulide Players by Revenue (2016-2021)
6.3 Japan Nimesulide Historic Market Review by Type (2016-2021)
6.3.1 Japan Nimesulide Sales Market Share by Type (2016-2021)
6.3.2 Japan Nimesulide Revenue Market Share by Type (2016-2021)
6.3.3 Japan Nimesulide Price by Type (2016-2021)
6.4 Japan Nimesulide Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Nimesulide Sales Forecast by Type (2022-2027)
6.4.2 Japan Nimesulide Revenue Forecast by Type (2022-2027)
6.4.3 Japan Nimesulide Price Forecast by Type (2022-2027)
6.5 Japan Nimesulide Historic Market Review by Application (2016-2021)
6.5.1 Japan Nimesulide Sales Market Share by Application (2016-2021)
6.5.2 Japan Nimesulide Revenue Market Share by Application (2016-2021)
6.5.3 Japan Nimesulide Price by Application (2016-2021)
6.6 Japan Nimesulide Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Nimesulide Sales Forecast by Application (2022-2027)
6.6.2 Japan Nimesulide Revenue Forecast by Application (2022-2027)
6.6.3 Japan Nimesulide Price Forecast by Application (2022-2027)

7 North America
7.1 North America Nimesulide Market Size YoY Growth 2016-2027
7.2 North America Nimesulide Market Facts & Figures by Country
7.2.1 North America Nimesulide Sales by Country (2016-2021)
7.2.2 North America Nimesulide Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Nimesulide Market Size YoY Growth 2016-2027
8.2 Asia Pacific Nimesulide Market Facts & Figures by Region
8.2.1 Asia Pacific Nimesulide Sales by Region (2016-2021)
8.2.2 Asia Pacific Nimesulide Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Nimesulide Market Size YoY Growth 2016-2027
9.2 Europe Nimesulide Market Facts & Figures by Country
9.2.1 Europe Nimesulide Sales by Country (2016-2021)
9.2.2 Europe Nimesulide Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Nimesulide Market Size YoY Growth 2016-2027
10.2 Latin America Nimesulide Market Facts & Figures by Country
10.2.1 Latin America Nimesulide Sales by Country (2016-2021)
10.2.2 Latin America Nimesulide Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Nimesulide Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Nimesulide Market Facts & Figures by Country
11.2.1 Middle East and Africa Nimesulide Sales by Country (2016-2021)
11.2.2 Middle East and Africa Nimesulide Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Helsinn
12.1.1 Helsinn Corporation Information
12.1.2 Helsinn Description and Business Overview
12.1.3 Helsinn Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Helsinn Nimesulide Products Offered
12.1.5 Helsinn Recent Development
12.2 Therabel
12.2.1 Therabel Corporation Information
12.2.2 Therabel Description and Business Overview
12.2.3 Therabel Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Therabel Nimesulide Products Offered
12.2.5 Therabel Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Corporation Information
12.3.2 Boehringer Ingelheim Description and Business Overview
12.3.3 Boehringer Ingelheim Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Boehringer Ingelheim Nimesulide Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Merck
12.4.1 Merck Corporation Information
12.4.2 Merck Description and Business Overview
12.4.3 Merck Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merck Nimesulide Products Offered
12.4.5 Merck Recent Development
12.5 Roche
12.5.1 Roche Corporation Information
12.5.2 Roche Description and Business Overview
12.5.3 Roche Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Roche Nimesulide Products Offered
12.5.5 Roche Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Description and Business Overview
12.6.3 Novartis Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novartis Nimesulide Products Offered
12.6.5 Novartis Recent Development
12.7 Medea Research
12.7.1 Medea Research Corporation Information
12.7.2 Medea Research Description and Business Overview
12.7.3 Medea Research Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Medea Research Nimesulide Products Offered
12.7.5 Medea Research Recent Development
12.8 Chinoin
12.8.1 Chinoin Corporation Information
12.8.2 Chinoin Description and Business Overview
12.8.3 Chinoin Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Chinoin Nimesulide Products Offered
12.8.5 Chinoin Recent Development
12.9 GSK
12.9.1 GSK Corporation Information
12.9.2 GSK Description and Business Overview
12.9.3 GSK Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.9.4 GSK Nimesulide Products Offered
12.9.5 GSK Recent Development
12.10 Alter
12.10.1 Alter Corporation Information
12.10.2 Alter Description and Business Overview
12.10.3 Alter Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Alter Nimesulide Products Offered
12.10.5 Alter Recent Development
12.11 Helsinn
12.11.1 Helsinn Corporation Information
12.11.2 Helsinn Description and Business Overview
12.11.3 Helsinn Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Helsinn Nimesulide Products Offered
12.11.5 Helsinn Recent Development
12.12 Rafa Laboratories
12.12.1 Rafa Laboratories Corporation Information
12.12.2 Rafa Laboratories Description and Business Overview
12.12.3 Rafa Laboratories Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Rafa Laboratories Products Offered
12.12.5 Rafa Laboratories Recent Development
12.13 Grunenthal
12.13.1 Grunenthal Corporation Information
12.13.2 Grunenthal Description and Business Overview
12.13.3 Grunenthal Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Grunenthal Products Offered
12.13.5 Grunenthal Recent Development
12.14 Pfizer
12.14.1 Pfizer Corporation Information
12.14.2 Pfizer Description and Business Overview
12.14.3 Pfizer Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Pfizer Products Offered
12.14.5 Pfizer Recent Development
12.15 Sanofi
12.15.1 Sanofi Corporation Information
12.15.2 Sanofi Description and Business Overview
12.15.3 Sanofi Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Sanofi Products Offered
12.15.5 Sanofi Recent Development
12.16 Italfarmaco
12.16.1 Italfarmaco Corporation Information
12.16.2 Italfarmaco Description and Business Overview
12.16.3 Italfarmaco Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Italfarmaco Products Offered
12.16.5 Italfarmaco Recent Development
12.17 Lepu Pharmaceutical
12.17.1 Lepu Pharmaceutical Corporation Information
12.17.2 Lepu Pharmaceutical Description and Business Overview
12.17.3 Lepu Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Lepu Pharmaceutical Products Offered
12.17.5 Lepu Pharmaceutical Recent Development
12.18 Nanchang Feihong Pharmaceutical
12.18.1 Nanchang Feihong Pharmaceutical Corporation Information
12.18.2 Nanchang Feihong Pharmaceutical Description and Business Overview
12.18.3 Nanchang Feihong Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Nanchang Feihong Pharmaceutical Products Offered
12.18.5 Nanchang Feihong Pharmaceutical Recent Development
12.19 Sinopharm
12.19.1 Sinopharm Corporation Information
12.19.2 Sinopharm Description and Business Overview
12.19.3 Sinopharm Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Sinopharm Products Offered
12.19.5 Sinopharm Recent Development
12.20 Guangdong Longxin Pharmaceutical
12.20.1 Guangdong Longxin Pharmaceutical Corporation Information
12.20.2 Guangdong Longxin Pharmaceutical Description and Business Overview
12.20.3 Guangdong Longxin Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Guangdong Longxin Pharmaceutical Products Offered
12.20.5 Guangdong Longxin Pharmaceutical Recent Development
12.21 Kangzhi Pharmaceutical
12.21.1 Kangzhi Pharmaceutical Corporation Information
12.21.2 Kangzhi Pharmaceutical Description and Business Overview
12.21.3 Kangzhi Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Kangzhi Pharmaceutical Products Offered
12.21.5 Kangzhi Pharmaceutical Recent Development
12.22 Hubei Shubang Pharmaceutical
12.22.1 Hubei Shubang Pharmaceutical Corporation Information
12.22.2 Hubei Shubang Pharmaceutical Description and Business Overview
12.22.3 Hubei Shubang Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Hubei Shubang Pharmaceutical Products Offered
12.22.5 Hubei Shubang Pharmaceutical Recent Development
12.23 Mudanjiang Lingtai Pharmaceutical
12.23.1 Mudanjiang Lingtai Pharmaceutical Corporation Information
12.23.2 Mudanjiang Lingtai Pharmaceutical Description and Business Overview
12.23.3 Mudanjiang Lingtai Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Mudanjiang Lingtai Pharmaceutical Products Offered
12.23.5 Mudanjiang Lingtai Pharmaceutical Recent Development
12.24 Guizhou Jisheng Pharmaceutical
12.24.1 Guizhou Jisheng Pharmaceutical Corporation Information
12.24.2 Guizhou Jisheng Pharmaceutical Description and Business Overview
12.24.3 Guizhou Jisheng Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Guizhou Jisheng Pharmaceutical Products Offered
12.24.5 Guizhou Jisheng Pharmaceutical Recent Development
12.25 Tianjin Hezhi Pharmaceutical Group
12.25.1 Tianjin Hezhi Pharmaceutical Group Corporation Information
12.25.2 Tianjin Hezhi Pharmaceutical Group Description and Business Overview
12.25.3 Tianjin Hezhi Pharmaceutical Group Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.25.4 Tianjin Hezhi Pharmaceutical Group Products Offered
12.25.5 Tianjin Hezhi Pharmaceutical Group Recent Development
12.26 Guangdong Yishu Pharmaceutical
12.26.1 Guangdong Yishu Pharmaceutical Corporation Information
12.26.2 Guangdong Yishu Pharmaceutical Description and Business Overview
12.26.3 Guangdong Yishu Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.26.4 Guangdong Yishu Pharmaceutical Products Offered
12.26.5 Guangdong Yishu Pharmaceutical Recent Development
12.27 Guangzhou Baiyunshan Pharmaceutical
12.27.1 Guangzhou Baiyunshan Pharmaceutical Corporation Information
12.27.2 Guangzhou Baiyunshan Pharmaceutical Description and Business Overview
12.27.3 Guangzhou Baiyunshan Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.27.4 Guangzhou Baiyunshan Pharmaceutical Products Offered
12.27.5 Guangzhou Baiyunshan Pharmaceutical Recent Development
12.28 Hainan Huluwa Pharmaceutical
12.28.1 Hainan Huluwa Pharmaceutical Corporation Information
12.28.2 Hainan Huluwa Pharmaceutical Description and Business Overview
12.28.3 Hainan Huluwa Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.28.4 Hainan Huluwa Pharmaceutical Products Offered
12.28.5 Hainan Huluwa Pharmaceutical Recent Development
12.29 Nanjing Zhengke Pharmaceutical
12.29.1 Nanjing Zhengke Pharmaceutical Corporation Information
12.29.2 Nanjing Zhengke Pharmaceutical Description and Business Overview
12.29.3 Nanjing Zhengke Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
12.29.4 Nanjing Zhengke Pharmaceutical Products Offered
12.29.5 Nanjing Zhengke Pharmaceutical Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Nimesulide Industry Trends
13.2 Nimesulide Market Drivers
13.3 Nimesulide Market Challenges
13.4 Nimesulide Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nimesulide Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

QYResearch社の分野での最新刊レポート

  • 最新刊レポートはありません。

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/04/30 10:26

143.57 円

163.67 円

195.09 円

ページTOPに戻る